Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants

Title
Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 10, Issue 10, Pages 2789-2794
Publisher
Informa UK Limited
Online
2014-07-09
DOI
10.4161/hv.29635

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started